An open-label phase I dose-finding study of APR-246 in hematological malignancies.

ABSTRACT:

SUBMITTER: Deneberg S 

PROVIDER: S-EPMC5141349 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature